Vincent Ma | Department of Medicine ...

Dr. Vincent Ma

Claim this profile

University of Wisconsin Carbone Cancer Center

Studies Skin Cancer
Studies Melanoma
7 reported clinical trials
14 drugs studied

Area of expertise

1

Skin Cancer

Vincent Ma has run 5 trials for Skin Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage I
2

Melanoma

Vincent Ma has run 4 trials for Melanoma. Some of their research focus areas include:

Stage IV
BRAF positive
MC1R positive

Affiliated Hospitals

Image of trial facility.

University Of Wisconsin - Carbone Cancer Center

Image of trial facility.

University Of Wisconsin Carbone Cancer Center - University Hospital

Clinical Trials Vincent Ma is currently running

Image of trial facility.

IPH5201 + Durvalumab + Chemotherapy

for Lung Cancer

The study is intended to assess the safety and efficacy of neoadjuvant combination of IPH5201 and durvalumab in addition to standard chemotherapy and adjuvant combination of IPH5201 and durvalumab in untreated patients with resectable, early-stage (stage II to IIIA) non-small cell lung cancer (NSCLC).

Recruiting

1 award

Phase 2

11 criteria

Image of trial facility.

Cemiplimab + Surgery

for Advanced Skin Cancer

This phase III trial compares the effect of adding cemiplimab to standard therapy (surgery with or without radiation) versus standard therapy alone in treating patients with stage III/IV squamous cell skin cancer that is able to be removed by surgery (resectable) and that may have come back after a period of improvement (recurrent). The usual treatment for patients with resectable squamous cell skin cancer is the removal of the cancerous tissue (surgery) with or without radiation, which uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cemiplimab has been approved for the treatment of skin cancer that has spread or that cannot be removed by surgery, but it has not been approved for the treatment of skin cancer than can be removed by surgery. Adding cemiplimab to the usual treatment of surgery with or without radiation may be more effective in treating patients with stage III/IV resectable squamous cell skin cancer than the usual treatment alone.

Recruiting

2 awards

Phase 3

7 criteria

More about Vincent Ma

Clinical Trial Related

2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical Trials

Treatments Vincent Ma has experience with

  • Pembrolizumab
  • Durvalumab
  • IPH5201
  • Standard Chemotherapy
  • Carboplatin
  • SEA-CD40

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Vincent Ma specialize in?

Is Vincent Ma currently recruiting for clinical trials?

Are there any treatments that Vincent Ma has studied deeply?

What is the best way to schedule an appointment with Vincent Ma?

What is the office address of Vincent Ma?

Is there any support for travel costs?